Subclinical Primary Aldosteronism: A Potential New Target in Cardiovascular Prevention?

Wanpen Vongpatanasin¹, Jesslin Abraham¹, John M Giacona^{1

2}

Affiliations

¹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX (W.V., J.A., J.M.G.).
² Department of Applied Clinical Research, School of Health Professions, University of Texas Southwestern Medical Center, Dallas, TX (J.M.G.).

Editorial

Wanpen Vongpatanasin et al. Circulation. 2025.

. 2025 Sep 30;152(13):924-926.

doi: 10.1161/CIRCULATIONAHA.125.076085. Epub 2025 Sep 29.

Wanpen Vongpatanasin¹, Jesslin Abraham¹, John M Giacona^{1

2}

¹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX (W.V., J.A., J.M.G.).
² Department of Applied Clinical Research, School of Health Professions, University of Texas Southwestern Medical Center, Dallas, TX (J.M.G.).

No abstract available

Keywords: Editorials; hyperaldosteronism.

Conflict of interest statement

None.

Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study.
Goupil R, Desbiens LC, Merabtine A, Agharazii M, Madore F, Vaidya A, Leung AA, Kline GA, Shaw JLV, Ramsay T, Nadeau-Fredette AC, Sood MM, Hundemer GL. Goupil R, et al. Circulation. 2025 Sep 30;152(13):913-923. doi: 10.1161/CIRCULATIONAHA.124.073507. Epub 2025 Jul 9. Circulation. 2025. PMID: 40631720